Literature DB >> 24285316

Current status of positron emission tomography radiotracers for serotonin receptors in humans.

Luc Zimmer1, Didier Le Bars.   

Abstract

Serotonin (5-HT) neurotransmission plays a key modulatory role in the brain. This system is critical for pathophysiological processes and many drug treatments for brain disorders interact with its 14 subtypes of receptors. Positron emission tomography (PET) is a unique tool for the study of the living brain in translational studies from animal models to patients in neurology or psychiatry. This short review is intended to cover the current status of PET radioligands used for imaging human brain 5-HT receptors. Here, we describe the available PET radioligands for the 5-HT1A , 5-HT1B , 5-HT2A , 5-HT4 and 5-HT6 receptors. Finally, we highlight the future challenges for a functional PET imaging of serotonin receptors, including the research towards specific PET radiotracers for yet unexplored serotonin receptors, the need of radiotracers for endogenous serotonin level measurement and the contribution of agonist radiotracers for functional imaging of 5-HT neurotransmission.
Copyright © 2013 John Wiley & Sons, Ltd.

Entities:  

Keywords:  PET; brain; radiopharmaceutical; receptor; serotonin

Mesh:

Substances:

Year:  2013        PMID: 24285316     DOI: 10.1002/jlcr.3001

Source DB:  PubMed          Journal:  J Labelled Comp Radiopharm        ISSN: 0362-4803            Impact factor:   1.921


  4 in total

Review 1.  PET tracers for serotonin receptors and their applications.

Authors:  J S Dileep Kumar; J John Mann
Journal:  Cent Nerv Syst Agents Med Chem       Date:  2014

2.  Synthesis and in vitro evaluation of [18F]FECIMBI-36: A potential agonist PET ligand for 5-HT2A/2C receptors.

Authors:  Jaya Prabhakaran; Mark D Underwood; J S Dileep Kumar; Norman R Simpson; Suham A Kassir; Mihran J Bakalian; J John Mann; Victoria Arango
Journal:  Bioorg Med Chem Lett       Date:  2015-07-20       Impact factor: 2.823

3.  Pharmacological agonists for more-targeted CNS radio-pharmaceuticals.

Authors:  Luc Zimmer
Journal:  Oncotarget       Date:  2016-12-06

Review 4.  The 5-HT1B receptor - a potential target for antidepressant treatment.

Authors:  Mikael Tiger; Katarina Varnäs; Yoshiro Okubo; Johan Lundberg
Journal:  Psychopharmacology (Berl)       Date:  2018-03-15       Impact factor: 4.530

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.